Gencell Ltd
GNCLF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 96.3% | -34.3% | 28.5% | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | -9.9% | -106.3% | -34.2% | -75.9% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -184.4% | -544.9% | -452.4% | -335.8% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -203.5% | -581.9% | -495.4% | -366.1% |
| EPS Diluted | -0.18 | -0.26 | -0.34 | -0.22 |
| % Growth | 30.8% | 23.5% | -54.5% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |